PVALB and early-onset autosomal dominant Alzheimer disease: Thus, the high metabolic load of parvalbumin-expressing interneurons makes them potentially vulnerable to failures in the vascular network due to aging, Alzheimer’s disease as well as stroke (Kann, 2016).